51 min listen
Dr. Liang Schweizer: Creating Targeted Antibodies in Single Cells
Dr. Liang Schweizer: Creating Targeted Antibodies in Single Cells
ratings:
Length:
52 minutes
Released:
Aug 20, 2022
Format:
Podcast episode
Description
Immunotherapies represent a powerful suite of treatments that co-opt the immune system to target deleterious cellular conditions. They have been effective with a series of cancers and other disorders. The problem is that development of new antibodies can be challenging for several technical reasons, but also because no two people are alike. Dr. Liang Schweizer of HiFiBio describes how her company is using single-cells and microfluidics to identify new antibodies that may be mobilized against discrete cellular targets, as well as what they have learned about heterogeneity between patients and how to identify specific biomarkers that could guide application of the most effective treatments.
Released:
Aug 20, 2022
Format:
Podcast episode
Titles in the series (100)
An Experiment You can Do With Us; Sugar Beet Breeding and Biology: This eThis episode of Talking Biotech invites you to be the investigator and data collector. The internet is littered with images that claim animals will not eat GMO corn, which is curious because 80% of it goes to animal feed. We have arranged to test by Talking Biotech with Dr. Kevin Folta